Unravelling Surface Modification Strategies for Preventing Medical Device‐Induced Thrombosis

Abstract

The use of biomaterials in implanted medical devices remains hampered by platelet adhesion and blood coagulation. Thrombus formation is a prevalent cause of failure of these blood‐contacting devices. Although systemic anticoagulant can be used to support materials and devices with poor blood compatibility, its negative effects such as an increased chance of bleeding, make materials with superior hemocompatibility extremely attractive, especially for long‐term applications. This review examines blood–surface interactions, the pathogenesis of clotting on blood‐contacting medical devices, popular surface modification techniques, mechanisms of action of anticoagulant coatings, and discusses future directions in biomaterial research for preventing thrombosis. In addition, this paper comprehensively reviews several novel methods that either entirely prevent interaction between material surfaces and blood components or regulate the reaction of the coagulation cascade, thrombocytes, and leukocytes.This article is protected by copyright. All rights reserved

Porous Microspheres as Pathogen Traps for Sepsis Therapy: Capturing Active Pathogens and Alleviating Inflammatory Reactions

“…It should be mentioned that red blood cells and white blood cells are not trapped due to the interception effect of microsphere surface pore size. The previous study proved that platelets are generally captured by materials through adhesion, aggregation, and activation . Therefore, platelets are not trapped by the low adhesion properties of the polyurethane.…”

“…The previous study proved that platelets are generally captured by materials through adhesion, aggregation, and activation. 52 Therefore, platelets are not trapped by the low adhesion properties of the polyurethane. The results indicate that microspheres do not have a significant impact on blood cells after direct contact with whole blood.…”

Recent advances in gel coatings: from lab to industry

“…Blood-contacting biomedical devices, including vascular stents, central venous catheters, hemodialysis catheters, peripherally inserted central catheters, and mechanical heart valves, are extensively utilized in the treatment of various diseases. 174–176 However, the occurrence of life-threatening complications such as thrombosis and infections continues to pose significant challenges in clinical practice. 80,90 The surfaces of polymer-based implants have a tendency to adsorb proteins, platelets, leukocytes, and red blood cells, among others, which can ultimately lead to the formation of thrombosis and infections.…”